Medexprim

📍 Toulouse, France🗓 Founded 2015👥 51 employees💰 Last funded Oct 2018
Research Services🌐 medexprim.com
Website LinkedIn
Medexprim is the European leader in secure imaging and clinical data extraction to accelerate medical research. As a Real-World data specialist, Medexprim builds bridges between European academic hospitals, and pharmaceutical, AI and medical device companies. In compliance with the GDPR, Medexprim helps hospitals boost their clinical research strategy and valorize their data, through a suite of software and services designed with and for clinicians. Medexprim provides its partners with secure access to complex, regulatory-grade, multimodal and multicentric datasets to serve oncology, neurology, cardiology and rare diseases, and help solve the "one patient, one disease, one treatment" equation to accelerate personalized medicine.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Medexprim?
Medexprim has 1 investors on record on gritt.io, 1 mid-stage.
When did Medexprim last raise funding?
The most recent investment in Medexprim recorded on gritt.io was in October 2018.
When was Medexprim founded?
Medexprim was founded in 2015.
What industry is Medexprim in?
Medexprim operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Medexprim based?
Medexprim is headquartered in Toulouse, France.